Introduction: Using the LCHD framework to understand and improve health outcomes for marginalized populations and promote equity from the start Part II
Related Posts
Guan M, Chang L. Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use. Gastroenterol Clin North Am. 2026 Mar;55(1):91-105. doi: 10.1016/j.gtc.2025.08.002. Epub 2025 Oct 21.[...]
Johnson SA, Klimis-Zacas D, Basu A, Bolling BW, Feresin RG, Hooshmand S, Joris PJ, Li Z, Lila MA, Stull AJ, Anandh Babu PV, Weir TL.[...]
Chirra AR, Manteuffel S, Runnels T, Sturgeon L, Alizondo MC, Tseng CH, Walling AM, Wenger NS. Using the Electronic Health Record Patient Portal to Collect[...]